164 related articles for article (PubMed ID: 35485696)
1. The Effects of Ibuprofen, Naproxen and Diclofenac on cell Apoptosis, Cell Proliferation and Histology Changes in Human Cholangiocarcinoma Cell Lines.
Leksomboon R; Kumpangnil K; Pangjit K; Udomsuk L
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1351-1358. PubMed ID: 35485696
[TBL] [Abstract][Full Text] [Related]
2. Ibuprofen and diclofenac differentially affect cell viability, apoptosis and morphology changes of human cholangiocarcinoma cell lines.
Leksomboon R; Kumpangnil K
J Taibah Univ Med Sci; 2022 Oct; 17(5):869-879. PubMed ID: 36050962
[TBL] [Abstract][Full Text] [Related]
3. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.
Yothaisong S; Dokduang H; Techasen A; Namwat N; Yongvanit P; Bhudhisawasdi V; Puapairoj A; Riggins GJ; Loilome W
Tumour Biol; 2013 Dec; 34(6):3637-48. PubMed ID: 23832540
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
Lister BJ; Poland M; DeLapp RE
Am J Med; 1993 Aug; 95(2A):2S-9S. PubMed ID: 8356999
[TBL] [Abstract][Full Text] [Related]
5. Synchrotron FTIR microspectroscopy revealed apoptosis-induced biomolecular changes of cholangiocarcinoma cells treated with ursolic acid.
Maphanao P; Thanan R; Loilome W; Chio-Srichan S; Wongwattanakul M; Sakonsinsiri C
Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129708. PubMed ID: 32810561
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines.
Dokduang H; Jamnongkarn W; Promraksa B; Suksawat M; Padthaisong S; Thanee M; Phetcharaburanin J; Namwat N; Sangkhamanon S; Titapun A; Khuntikeo N; Klanrit P; Loilome W
Drug Des Devel Ther; 2020; 14():2319-2334. PubMed ID: 32606601
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines.
Hahnvajanawong C; Boonyanugomol W; Nasomyon T; Loilome W; Namwat N; Anantachoke N; Tassaneeyakul W; Sripa B; Namwat W; Reutrakul V
World J Gastroenterol; 2010 May; 16(18):2235-43. PubMed ID: 20458760
[TBL] [Abstract][Full Text] [Related]
8. [Acetylsalicylic acid? Ibuprofen? Acetaminophen? Which one?].
Cloutier L; Chabot JB; Lemay C
Perspect Infirm; 2014; 11(4):42-7. PubMed ID: 25269240
[No Abstract] [Full Text] [Related]
9. The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines.
Samatiwat P; Tabtimmai L; Suphakun P; Jiwacharoenchai N; Toviwek B; Kukongviriyapan V; Gleeson MP; Choowongkomon K
Asian Pac J Cancer Prev; 2021 Feb; 22(2):381-390. PubMed ID: 33639651
[TBL] [Abstract][Full Text] [Related]
10. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.
Tepsiri N; Chaturat L; Sripa B; Namwat W; Wongkham S; Bhudhisawasdi V; Tassaneeyakul W
World J Gastroenterol; 2005 May; 11(18):2748-53. PubMed ID: 15884115
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the blood pressure changes of lumiracoxib with those of ibuprofen and naproxen.
Farkouh ME; Verheugt FW; Ruland S; Kirshner H; Jeger R; Gitton X; Krammer G; Stricker K; Sallstig P; Mellein B; Matchaba P; Chesebro JH
J Clin Hypertens (Greenwich); 2008 Aug; 10(8):592-602. PubMed ID: 18772641
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly.
Morgan GJ; Poland M; DeLapp RE
Am J Med; 1993 Aug; 95(2A):19S-27S. PubMed ID: 8356998
[TBL] [Abstract][Full Text] [Related]
13. BI6727 and GSK461364A, potent PLK1 inhibitors induce G2/M arrest and apoptosis against cholangiocarcinoma cell lines.
Riantana H; Waenphimai O; Mahalapbutr P; Karnchanapandh K; Vaeteewoottacharn K; Wongkham S; Sawanyawisuth K
Pathol Res Pract; 2023 Aug; 248():154678. PubMed ID: 37454493
[TBL] [Abstract][Full Text] [Related]
14. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
[TBL] [Abstract][Full Text] [Related]
15. Multiple actions of NMS-P715, the monopolar spindle 1 (MPS1) mitotic checkpoint inhibitor in liver fluke-associated cholangiocarcinoma cells.
Waenphimai O; Mahalapbutr P; Vaeteewoottacharn K; Wongkham S; Sawanyawisuth K
Eur J Pharmacol; 2022 May; 922():174899. PubMed ID: 35337815
[TBL] [Abstract][Full Text] [Related]
16. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
van Staa TP; Rietbrock S; Setakis E; Leufkens HG
J Intern Med; 2008 Nov; 264(5):481-92. PubMed ID: 18624902
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells.
Buranrat B; Senggunprai L; Prawan A; Kukongviriyapan V
Life Sci; 2016 May; 153():41-9. PubMed ID: 27098189
[TBL] [Abstract][Full Text] [Related]
18. Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype.
van Dijk KN; Plat AW; van Dijk AA; Piersma-Wichers M; de Vries-Bots AM; Slomp J; de Jong-van den Berg LT; Brouwers JR
Thromb Haemost; 2004 Jan; 91(1):95-101. PubMed ID: 14691574
[TBL] [Abstract][Full Text] [Related]
19. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways.
Prakobwong S; Gupta SC; Kim JH; Sung B; Pinlaor P; Hiraku Y; Wongkham S; Sripa B; Pinlaor S; Aggarwal BB
Carcinogenesis; 2011 Sep; 32(9):1372-80. PubMed ID: 21325634
[TBL] [Abstract][Full Text] [Related]
20. Preclinical comparison of antinociceptive effects between ibuprofen, diclofenac, naproxen, and acetaminophen on acid-stimulated body stretching and acid-depressed feeding behaviors in rats.
Altarifi AA; Younis BA; Nuseir KQ; Al-Mousa AA; Qaoud AK; Alsalem MI; Neubert JK
Behav Pharmacol; 2022 Dec; 33(8):567-574. PubMed ID: 36256732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]